These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 475365)

  • 1. Correlation of netilmicin disk diffusion susceptibility and agar dilution susceptibility.
    Fu KP; Neu HC
    Antimicrob Agents Chemother; 1979 Jun; 15(6):834-5. PubMed ID: 475365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibility studies with netilmicin: comparison of a 10-microgram netilmicin disk with a standardized 10-microgram gentamicin disk.
    Habwe V; Shadomy S
    Antimicrob Agents Chemother; 1978 Jun; 13(6):1046-8. PubMed ID: 98106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of medium composition on bacterial susceptibility testing to gentamicin and netilmicin.
    Dornbusch K
    Scand J Infect Dis Suppl; 1980; Suppl 23():46-53. PubMed ID: 6937968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tentative interpretive criteria for the diffusion susceptibility test using 30-microgram netilmicin disks.
    Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1980 Sep; 18(3):487-90. PubMed ID: 7425615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of interpretive breakpoints for netilmicin disk susceptibility tests with Pseudomonas aeruginosa.
    Barry AL; Miller GH; Hare RS; Jones RN; Thornsberry C
    J Clin Microbiol; 1984 Mar; 19(3):311-4. PubMed ID: 6425354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of netilmicin agar dilution and disk diffusion susceptibilities.
    Goldmann DA; Syriopoulou GP; Semple AM
    Antimicrob Agents Chemother; 1977 Aug; 12(2):288-9. PubMed ID: 900923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality control parameters for susceptibility tests with 30-micrograms netilmicin disks.
    Barry AL; Gavan TL; Jones RN
    J Clin Microbiol; 1983 Nov; 18(5):1051-4. PubMed ID: 6643655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of cation supplements on activity of netilmicin against Pseudomonas aeruginosa in vitro and in vivo.
    Barry AL; Miller GH; Thornsberry C; Hare RS; Jones RN; Lorber RR; Ferraresi R; Cramer C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1514-8. PubMed ID: 3124731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin: in-vitro activity compared with that of other aminoglycosides against Serratia marcescens.
    Langstaff D; Schueler S; Righter J
    J Antimicrob Chemother; 1983 Feb; 11(2):187-9. PubMed ID: 6339461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of disk diffusion and agar dilution methods for gentamicin susceptibility testing of Neisseria gonorrhoeae.
    Gianecini R; Oviedo C; Irazu L; Rodríguez M; ; Galarza P
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):299-304. PubMed ID: 29709312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro comparison of gentamicin and netilmicin including a regression line for netilmicin.
    Bang J; Mortensen I; Bentzon MW
    Scand J Infect Dis Suppl; 1980; Suppl 23():34-8. PubMed ID: 6782656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Netilmicin synergy with carbenicillin or cefamandole against Serratia.
    Flournoy DJ
    J Antibiot (Tokyo); 1978 Feb; 31(2):131-4. PubMed ID: 632223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of Helicobacter pylori to metronidazole.
    Perna F; Gatta L; Figura N; Ricci C; Tampieri A; Holton J; Miglioli M; Vaira D
    Am J Gastroenterol; 2003 Oct; 98(10):2157-61. PubMed ID: 14572561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of netilmicin susceptibility discs using bacteria with known aminoglycoside resistance patterns: correlation of in vitro and in vivo test results.
    Waitz JA; Hare RS; Moss EL; Sabatelli FJ; Schaffer TW; Waitz JA
    Scand J Infect Dis Suppl; 1980; Suppl 23():62-72. PubMed ID: 6937970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of 327 clinical isolates to netilmicin.
    Digranes A; Ostervold B; Madsen ST; Solberg CO; Haeger K
    J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inability of the standardized disk agar-diffusion test to measure susceptibility of the fluorescent group of pseudomonads to gentamicin.
    Woolfrey BF; Ramadei WA; Quall CO
    Am J Clin Pathol; 1978 Sep; 70(3):337-42. PubMed ID: 101077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A; Dibb WL; Benonisen E; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.